Dendreon Corp fka DNDNQ

[stuck_holder]

Congratulations to AIPC patients, DNDN management, and all DNDN longs, especially those posters on these MBs who contributed to an objective understanding of the science risks to laypeople like myself. (You know who you are.)

Tomorrow should indeed be an interesting day - the long night's journey for DNDN shareholders has passed into the dawn of a new era in cancer treatment, with the light beginning to shine brightly on Provenge as it basks in the glow of FDA approval.

Cheers.